No Data
No Data
Chongqing Zhifei Biological Products (SZSE:300122) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Three Years, but the Stock Advances 4.4% This Past Week
Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement
Express News | Chongqing Zhifei Biological Products Says Co Will Work With GSK in Commercialization of Rsv Vaccines in China
Express News | Chongqing Zhifei Biological Products Says Co Adjusted Terms on Cooperation With GSK on Recombinant Zoster Vaccine Procurement Plans
Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) CEO Rensheng Jiang, the Company's Largest Shareholder Sees 7.3% Reduction in Holdings Value
Express News | Zhifei Biological Products Says Q3 Net Loss at 83.7 Mln Yuan